Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ferreri CJ"'
Autor:
Sidana S; Stanford University, Palo Alto, California, United States., Patel KK; The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States., Peres LC; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States., Bansal R; Mayo Clinic Hospital, New York, New York, United States., Kocoglu MH; University of Maryland, Baltimore, Maryland, United States., Shune L; University of Kansas, Westwood, Kansas, United States., Atrash S; Atrium Health, Charlotte, North Carolina, United States., Smith K; Medical College of Wisconsin, Milwaukee, Wisconsin, United States., Midha S; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Ferreri CJ; Atrium Health Wake Forest Baptist Levine Cancer Institute, Charlotte, North Carolina, United States., Dhakal B; Medical College of Wisconsin, Wauwatosa, Wisconsin, United States., Dima D; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, United States., Costello P; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Wagner C; Huntsman Cancer Institute, Salt Lake City, Utah, United States., Reshef R; Columbia University Medical Center, New York, New York, United States., Hosoya H; Stanford University, Palo Alto, California, United States., Mikkilineni L; Stanford University School of Medicine, Palo Alto, California, United States., Atanackovic D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States., Chhabra S; Mayo Clinic Arizona, Phoenix, Arizona, United States., Parrondo RD; Mayo Clinic Florida, Jacksonville, Florida, United States., Nadeem O; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Mann H; Virginia Commonwealth University, Richmond, Virginia, United States., Kalariya N; UT MD Anderson Cancer Center, Houston, Texas, United States., Hovanky V; Stanford University School of Medicine, Stanford, California, United States., DeAvila G; H. Lee Moffitt Cancer Center, Tampa, Florida, United States., Freeman CL; H. Lee Moffitt Cancer Center, Tampa, Florida, United States., Locke FL; Moffitt Cancer Center, Tampa, Florida, United States., Alsina M; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States., Wong S; University of California San Francisco, San Francisco, California, United States., Herr MM; Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States., Htut M; City of Hope, Duarte, California, United States., McGuirk JP; University of Kansas Cancer Center, Westwood, Kansas, United States., Sborov DW; Huntsman Cancer Institute / University of Utah, Salt Lake City, Utah, United States., Khouri J; Cleveland Clinic, Cleveland, Ohio, United States., Martin T; UCSF, San Francisco, California, United States., Janakiram M; City Of Hope National Medical Center, DUARTE, California, United States., Lin Y; Mayo Clinic, Rochester, Minnesota, United States., Hansen DK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States.
Publikováno v:
Blood [Blood] 2024 Oct 04. Date of Electronic Publication: 2024 Oct 04.
Autor:
Kalariya NM; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Hildebrandt MAT; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Hansen DK; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Sidana S; Stanford University School of Medicine, Stanford, CA., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH., Ferreri CJ; Atrium Health, Wake Forest University School of Medicine, Levine Cancer Institute, Charlotte, NC., Doyle WN; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Castaneda-Puglianini O; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Freeman CL; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Hovanky V; Stanford University School of Medicine, Stanford, CA., Hosoya H; Stanford University School of Medicine, Stanford, CA., Shune LO; The University of Kansas Medical Center, Kansas City, KS., Patel KK; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4679-4688.
Autor:
Ferreri CJ; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC, United States., Bhutani M; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 May 21; Vol. 14, pp. 1396490. Date of Electronic Publication: 2024 May 21 (Print Publication: 2024).
Autor:
Afrough A; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. Aimaz.afrough@utsouthwestern.edu., Hashmi H; Medical University of South Carolina, Charleston, SC, USA., Hansen DK; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Sidana S; Stanford University School of Medicine, Stanford, CA, USA., Ahn C; Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA., Peres LC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Freeman CL; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Puglianini OC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Kocoglu MH; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Atrash S; Levine Cancer Institute, Charlotte, NC, USA., Voorhees PM; Levine Cancer Institute, Charlotte, NC, USA., Shune L; The University of Kansas Medical Center, Kansas City, KS, USA., McGuirk JP; The University of Kansas Medical Center, Kansas City, KS, USA., Simmons G; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA., Sborov DW; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Davis JA; Medical University of South Carolina, Charleston, SC, USA., Kaur G; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Sannareddy A; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Ferreri CJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gaballa MR; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Goldsmith S; City of Hope National Medical Center, Duarte, CA, USA., Nadeem O; Dana-Farber Cancer Institute, Boston, MA, USA., Midha S; Dana-Farber Cancer Institute, Boston, MA, USA., Wagner CB; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Locke FL; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Patel KK; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Anderson LD Jr; Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. larry.anderson@utsouthwestern.edu., Lin Y; Mayo Clinic, Rochester, MN, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Apr 12; Vol. 14 (1), pp. 63. Date of Electronic Publication: 2024 Apr 12.
Autor:
Ferreri CJ; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health/Wake Forest Baptist, Charlotte, North Carolina.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Feb; Vol. 30 (2), pp. 126-128.
Autor:
Ferreri CJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hildebrandt MAT; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hashmi H; Medical University of South Carolina, Charleston, SC, USA., Shune LO; The University of Kansas Medical Center, Kansas City, KS, USA., McGuirk JP; The University of Kansas Medical Center, Kansas City, KS, USA., Sborov DW; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Wagner CB; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Kocoglu MH; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Rapoport A; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Atrash S; Levine Cancer Institute, Charlotte, NC, USA., Voorhees PM; Levine Cancer Institute, Charlotte, NC, USA., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Afrough A; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Kaur G; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Anderson LD Jr; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Simmons G; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA., Davis JA; Medical University of South Carolina, Charleston, SC, USA., Kalariya N; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Peres LC; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lin Y; Mayo Clinic, Rochester, MN, USA., Janakiram M; City of Hope, Duarte, CA, USA., Nadeem O; Dana-Farber Cancer Institute, Boston, MA, USA., Alsina M; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Locke FL; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sidana S; Stanford University School of Medicine, Stanford, CA, USA., Hansen DK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patel KK; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. KPatel1@mdanderson.org., Castaneda Puglianini OA; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Aug 09; Vol. 13 (1), pp. 117. Date of Electronic Publication: 2023 Aug 09.
Autor:
Ferreri CJ; From the Division of Cancer Medicine., Lee HC; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Cancer journal (Sudbury, Mass.) [Cancer J] 2022 Nov-Dec 01; Vol. 28 (6), pp. 488-495.